Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODERNISE: Moderate vs Deep Sedation in Neuro-ICU
NCT02317497Phase 2Unknown
- Sponsor
- Heidelberg University
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Heidelberg University. Primary endpoint: Intensive Care Unit Length of Stay. Status: unknown.
Beyond the preview
Go deeper on NCT02317497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317497.